Skip to main content
Clinical Trials/NL-OMON42073
NL-OMON42073
Completed
Not Applicable

The role of the serotonin transporter in citalopram pharmacological MRI - SERT-phMRI

Academisch Medisch Centrum0 sites45 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
serotonine systeem
Sponsor
Academisch Medisch Centrum
Enrollment
45
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Three groups of N \= 15 each: healthy female volunteers, aged between 18 and 30 without any harddrug exposure including MDMA.

Exclusion Criteria

  • Serious general medical condition or one that could interfere in the interpretation of results, use of (5\-HT) medication or supplements and / or illicit (hard) drug use within the last 2 weeks, excessive consumption of alcohol (\>21 units/ week), caffeine (greater than eight cups of coffee per day) or cigarette (greater than 15 cigarettes per day), allergy to iodine tablets, contraindications for MRI (e.g. ferromagnetic osteosynthetic material, pacemaker, artificial cardiac valves, claustrophobia), abnormal ECG, or pregnant (a pregnancy test will be administered every visit).

Outcomes

Primary Outcomes

Not specified

Similar Trials